Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Pedestrian Killed in Train Crash on N. San Fernando Road


Victim Dies in Fatal Pacoima Accident

Pacoima, CA (April 7, 2020) – One person was killed in a train crash in Pacoima. The fatal accident occurred on the morning of April 7 on N. San Fernando Road.

A pedestrian was hit by Metrolink AV line Train No. 212 in the 9800 block of N. San Fernando Road. The victim died at the accident scene. Nobody aboard the train was injured. The cause of the crash is under investigation.

#Pacoima

#91331


October 2, 2019

Boy Killed, 2 Others Injured in Pedestrian Crash at Cooper Road and Anita Avenue

Victims Hit in Crosswalk in Fatal Oxnard Accident Oxnard, CA (September 30, 201...


March 3, 2020

Man Killed in Crash at Snell and Rosenbaum Avenues

Driver Hits Metal Barrier in Fatal San Jose Accident...


March 26, 2020

PG&E Truck Driver Injured in Crash on Interstate 80 Near Antelope Truck Scales

2 Trucks Collide in Citrus Heights Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.